Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 1 1

Status

Recruiting 3Completed 3Terminated 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Other solid neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Lymphoma 306Lymphoma, Non-Hodgkin 227Lymphoma, Large B-Cell, Diffuse 220Lymphoma, Follicular 201Leukemia, Lymphocytic, Chronic, B-Cell 168Lymphoma, B-Cell 147Recurrence 124Burkitt Lymphoma 117Lymphoma, Mantle-Cell 112Leukemia, Myeloid, Acute 106Leukemia 103Hodgkin Disease 102Multiple Myeloma 95Lymphoma, B-Cell, Marginal Zone 87Neoplasms 80Myelodysplastic Syndromes 69Lymphoma, T-Cell, Peripheral 62Hematologic Neoplasms 61Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 58Lymphoma, T-Cell 52Lymphoma, T-Cell, Cutaneous 44Waldenstrom Macroglobulinemia 41Leukemia, Biphenotypic, Acute 35Mycosis Fungoides 31Lymphoproliferative Disorders 30Leukemia, B-Cell 30Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Breast Neoplasms 28Myeloproliferative Disorders 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × B-cell Malignancies × Lymphoid × Clear all
NCT07349849 2026-01-20

Exploratory Study on mRNA Therapeutic Drug Targeting CD19 for the Treatment of Hematologic Malignancies

Xinqiao Hospital of Chongqing

Phase EARLY_PHASE1 Recruiting
47 enrolled
Lymphoid

B-cell Malignancies

NCT07065279 2025-07-15

JY231(JY231) Injection for the Treatment of R/R B-cell Malignancies

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

Phase NA Recruiting
36 enrolled
Lymphoid

B-cell Malignancies

NCT06958679 2025-05-14

Evaluation of SYS6005 in Patients With Advanced Malignant Tumor

CSPC Megalith Biopharmaceutical Co.,Ltd.

Phase 1 Recruiting
132 enrolled
LymphoidOther solid neoplasm

B-cell Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡